Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on the Long-Term Safety and Effectiveness of Pegunigalsidase Alfa for Adults with Fabry Disease
BelgiumStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
BelgiumStudy on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer
LithuaniaStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on Anifrolumab and Phototherapy for Adults with Progressive Vitiligo
FranceStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
AustriaStudy on the Safety and Effectiveness of Imiquimod Gel and Cream for Treating Actinic Keratosis in Adults
SpainStudy on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis
GermanyStudy of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris
ItalyStudy on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines
GermanyStudy of MaaT013 (Fecal Transplantation) Combined with Ipilimumab and Nivolumab in Patients with Previously Untreated Melanoma
FranceStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
AustriaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
